Fluorescence In Situ Hybridization Probe Validation for Clinical Use

Area of Science:

• Molecular Biology
• Clinical Diagnostics
• Biotechnology

Background:

• Fluorescence in situ hybridization (FISH) probes are vital tools in clinical diagnostics and research.
• Commercial FISH probes in the U.S. are regulated by FDA, CDC, CMS, CLIA, and CAP.
• Home-brewed FISH probes, though not directly regulated, require equivalent validation.

Purpose of the Study:

• To systematically review published guidelines for validating fluorescence in situ hybridization (FISH) probes.
• To outline the validation procedures for both commercial and in-house developed FISH probes for clinical diagnostic applications.
• To ensure the reliability and accuracy of FISH probe usage in clinical settings.

Main Methods:

• Systematic overview of published guidelines and validation procedures for FISH probes.
• Classification of FISH probes as molecular probes or analyte-specific reagents (ASRs).
• Description of initial validation and ongoing verification processes for FISH test systems.

Main Results:

• FISH probe validation encompasses technical specifications, standard operational procedures (SOPs), and analytical validation.
• Key validation steps include determining clinical sensitivity, specificity, cutoff values, and reference ranges.
• Ongoing verification ensures the continued accuracy and reliability of the FISH test system over time.

Conclusions:

• Both commercial and home-brewed FISH probes necessitate comprehensive validation prior to clinical deployment.
• Rigorous validation protocols are essential for maintaining the integrity of FISH-based diagnostic testing.
• Standardized validation ensures the accurate detection of abnormalities for improved patient outcomes.